Proposed Data Collections Submitted for Public Comment and Recommendations, 38937-38938 [05-13245]
Download as PDF
<![CDATA[
38937
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Morbidity Monitoring Project
(MMP)—New—National Center for HIV,
STD and TB Prevention (NCHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description:
This proposed data collection
supplements the HIV/AIDS surveillance
programs in 26 selected state and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
infection and AIDS and will incorporate
data elements from two data collections:
regimens. Collection of data from
patient medical records will provide
information on: demographics and
insurance status; the prevalence and
incidence of AIDS-defining
opportunistic illnesses and comorbidities related to HIV disease; the
receipt of prophylactic and
antiretroviral medications; and whether
patients are receiving screening and
treatment according to Public Health
Service guidelines. No other Federal
agency collects national populationbased behavioral and clinical
information from HIV-infected adults in
care. The data will have significant
implications for policy, program
development, and resource allocation at
the state/local and national levels.
CDC is requesting approval for a 3year clearance for data collection. Data
will be collected by 26 Reporting Areas
(19 states, Puerto Rico and 6 separately
funded cities). CDC estimates an average
of 400 respondents per site, resulting in
10,400 respondents for the interview
portion. There will be 2 medical record
abstractors per site, resulting in 52
respondents for the medical record
abstraction. Participation of respondents
is voluntary and there is no cost to the
respondents other than their time.
Supplement to HIV/AIDS Surveillance
(SHAS) project (0920–0262) and the
Adult/Adolescent Spectrum of HIV
Disease (ASD). Both projects stopped
data collection in 2004.
Although CDC receives surveillance
data from all U.S. states, these
supplemental surveillance data are
needed to make estimates of key
indicators, such as quality of HIVrelated ambulatory care and the severity
of need for HIV-related care and
services. A large number of cities and
states are heavily impacted by the HIV/
AIDS epidemic, resulting in the need for
population-based national estimates of
HIV-related behaviors, clinical
outcomes, and quality of HIV care.
This project will collect data on
behaviors and clinical outcomes from a
probability sample of HIV-infected
adults receiving care in the U.S.
Collection of data from interviews with
HIV-infected patients will provide
information on patient demographics,
and the current levels of behaviors that
may facilitate HIV transmission: sexual
and drug use behaviors; patients’ access
to, use of and barriers to HIV-related
secondary prevention services;
utilization of HIV-related medical
services; and adherence to drug
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
sites
Type of data collection
Average number of respondents/site
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Persons interviewed .................................
Medical record abstractors ......................
26
26
400
2
10,400
52
1
200
45/60
1
7,800
10,400
Total ..................................................
........................
........................
........................
........................
........................
18,200
Dated: June 21, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–13244 Filed 7–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0425X]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
The National Centers for Autism and
Developmental Disabilities Research
and Epidemiology (CADDRE) Study—
New—National Center for Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Children’s Health Act of 2000
mandated CDC to establish autism
surveillance and research programs to
address the number, incidence,
correlates, and causes of autism and
related disabilities. Under the
E:\FR\FM\06JYN1.SGM
06JYN1
38938
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
provisions of this act, CDC funded 5
CADDRE centers including the
California Department of Health and
Human Services, Colorado Department
of Public Health and Environment,
Johns Hopkins University, the
University of Pennsylvania, and the
University of North Carolina at Chapel
Hill. CDC National Center for Birth
Defect and Developmental Disabilities
will participate as the 6th site. The
multi-site, collaborative study will be an
epidemiological investigation of
possible causes for the autism spectrum
disorders.
developmental and physical exam of the
child participant; (7) biological
sampling of the child participant (blood
and hair); and, (8) biological sampling of
the biological parents of the child
participant (blood only). OMB clearance
is requested for the self administered
questionnaires and buccal swab kit, the
primary caregiver interview, and the
child development interview. There is
no cost to respondents other than their
time.
Data collection methods will consist
of the following: (1) Medical and
educational record review of the child
participant; (2) medical record review of
the biological mother of the child
participant; (3) a packet sent to the
participants with self-administered
questionnaires and a buccal swab kit; (4)
a telephone interview focusing on
pregnancy-related events and early life
history (biological mother and/or
primary caregiver interview); (5) a child
development interview (for case
participants only) administered over the
telephone or in-person; (6) a
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Survey
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Total burden
(in hrs.)
Cases:
—Self administered questionnaires and buccal swab kit .........................
—Primary caregiver interview ...................................................................
—Child development interview .................................................................
Controls:
—Self administered questionnaires and buccal swab kit .........................
—Primary caregiver interview ...................................................................
—Child development interview .................................................................
644
644
644
1
1
1
3.0
40/60
3.0
1932
429
1932
1288
1288
1288
1
1
1
3.0
40/60
1.0
3864
859
1288
Total ...................................................................................................
........................
........................
........................
10,304
Dated: June 21, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–13245 Filed 7–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–05–0010]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
The National Birth Defects Prevention
Study (OMB 0920–0010)—Extension—
The Division of Birth Defects and
Developmental Disabilities (DBDDD),
National Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Background and Brief Description
CDC has been monitoring the
occurrence of serious birth defects and
genetic diseases in Atlanta since 1967
through the Metropolitan Atlanta
Congenital Defects Program (MACDP).
The MACDP is a population-based
surveillance system for birth defects in
the 5 counties of Metropolitan Atlanta.
Its primary purpose is to describe the
spatial and temporal patterns of birth
defects occurrence and serve as an early
warning system for new teratogens.
From 1993 to 1996, the Division of Birth
Defects and Developmental Disabilities
(DBDDD) conducted the Birth Defects
Risk Factor Surveillance (BDRFS) study,
a case-control study of risk factors for
selected birth defects. Infants with birth
defects were identified through MACDP
and maternal interviews and clinical/
laboratory tests were conducted on
approximately 300 cases and 100
controls per year. Controls were selected
from among normal births in the same
population. In 1997 the BDRFS became
the National Birth Defects Prevention
Study (NBDPS). The major components
of the study did not change.
The NBDPS is a case-control study of
major birth defects that includes cases
identified from existing birth defect
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 70, Number 128 (Wednesday, July 6, 2005)]
[Notices]
[Pages 38937-38938]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13245]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-0425X]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
The National Centers for Autism and Developmental Disabilities
Research and Epidemiology (CADDRE) Study--New--National Center for
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Children's Health Act of 2000 mandated CDC to establish autism
surveillance and research programs to address the number, incidence,
correlates, and causes of autism and related disabilities. Under the
[[Page 38938]]
provisions of this act, CDC funded 5 CADDRE centers including the
California Department of Health and Human Services, Colorado Department
of Public Health and Environment, Johns Hopkins University, the
University of Pennsylvania, and the University of North Carolina at
Chapel Hill. CDC National Center for Birth Defect and Developmental
Disabilities will participate as the 6th site. The multi-site,
collaborative study will be an epidemiological investigation of
possible causes for the autism spectrum disorders.
Data collection methods will consist of the following: (1) Medical
and educational record review of the child participant; (2) medical
record review of the biological mother of the child participant; (3) a
packet sent to the participants with self-administered questionnaires
and a buccal swab kit; (4) a telephone interview focusing on pregnancy-
related events and early life history (biological mother and/or primary
caregiver interview); (5) a child development interview (for case
participants only) administered over the telephone or in-person; (6) a
developmental and physical exam of the child participant; (7)
biological sampling of the child participant (blood and hair); and, (8)
biological sampling of the biological parents of the child participant
(blood only). OMB clearance is requested for the self administered
questionnaires and buccal swab kit, the primary caregiver interview,
and the child development interview. There is no cost to respondents
other than their time.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Survey respondents responses per response (in (in hrs.)
respondent hrs.)
----------------------------------------------------------------------------------------------------------- ---------
Cases:
--Self administered questionnaires and 644 1 3.0 1932
buccal swab kit.......................
--Primary caregiver interview.......... 644 1 40/60 429
--Child development interview.......... 644 1 3.0 1932
Controls:
--Self administered questionnaires and 1288 1 3.0 3864
buccal swab kit.......................
--Primary caregiver interview.......... 1288 1 40/60 859
--Child development interview.......... 1288 1 1.0 1288
-----------------
Total.............................. .............. .............. .............. 10,304
----------------------------------------------------------------------------------------------------------------
Dated: June 21, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-13245 Filed 7-5-05; 8:45 am]
BILLING CODE 4163-18-P
